American Gastroenterological Association Freston Single Topic Conference 2021

Description

+ Include: 16 videos, size: 7.59 GB

+ Target Audience: gastroenterologists

+ Sample video: contact me for sample video

+ Information:

The AGA Freston Single Topic Conference 2021 is an intensive, research-driven meeting focused on one high-impact theme in gastroenterology. Designed to bridge basic science and clinical practice, the conference features keynote talks, state-of-the-art reviews, and interactive discussions that translate emerging mechanisms into practical diagnostics and therapies.

What You Will Learn

• Current mechanistic insights and how they inform GI disease pathophysiology

• Evidence-based diagnostic pathways and biomarker use for the featured topic

• Therapeutic strategies, including optimized use of established agents and integration of novel therapies

• Clinical trial interpretation and how to apply results in day-to-day care

• Approaches to special populations and real-world implementation in diverse care settings

Event Details

• Year: 2021

• Format: Multi-session scientific program with plenary lectures, focused symposia, and panel Q&A

• Access: Live presentations with on-demand viewing of select sessions (as scheduled by the organizer)

Who Should Attend

• Gastroenterologists, hepatologists, and GI researchers

• Fellows, residents, and medical students interested in translational GI science

• Advanced practice providers, nurses, and pharmacists involved in GI patient care

• Industry and academic scientists focused on GI drug and biomarker development

Why Attend

• Get a concentrated, up-to-date examination of a single high-value GI topic

• Learn directly from leaders who shape guidelines and research agendas

• Bring home practical algorithms and management pearls you can apply immediately

• Network with peers across academic, community, and research settings

 

+ Topics:

EoE BUILDING A BETTER PATH: EOSINOPHILS IN EOE

• Introduction Alex Straumann, MD – University of Zurich
• Historical Perspective on EoE: Charting an Undiscovered Disease Stephen Attwood, MD – Durham University, United Kingdom
• Global impact and Historical Perspective Alex Straumann, MD – University of Zurich
• Patient Presentations – Consider Patient 0 Patient Jeffery O. and Mary M.

EoE – Pathogenesis Moderator Introduction  Sandeep Gupta, MD – Indiana University

• Epidemiology: When and Where Did the Path Begin? Evan Dellon, MPH, MD – University of North Carolina School of Medicine
• Genetics and Epigenetics: Genetic Determinants of the Path Marc Rothenberg, MD, PhD – Children’s Hospital Medical Center
• Fibrosis: Influence of Subepithelial Activity on the Path Seema Aceves, PhD, MD – University of California, San Diego School of Medicine
• Allergic Mechanisms: Crossroads with Food, Environmental and Extraesophageal Atopy (OIT, Food, Environmental) Jonathan Spergel, MD, PhD – Children’s Hospital of Philadelphia
• Mast Cells and Epithelial Barrier Dysfunction: Inroads and Crossroads Joshua Wechsler, MD – Ann & Robert H. Lurie Children’s Hospital of Chicago
• Summary and Discussion Quan Nhu, MD, Dominique Bailey, MD and Joy Chang, MD

EoE – Therapeutic Advances Moderator Introduction David Katzka, MD – Mayo Clinic

• Diet Therapy Alfredo Lucendo, MD, PhD – Hospital General de Tomelloso
• PPIs: Mechanism and Pathways in the Post AGREE Era Javier Molina-Infante, MD, PhD – Universitario San Pedro de Alcantara
• Swallowed Topical Steroids: Repaving a Well-Trodden Path (Efficacy of Newest Agents, Maintenance, Safety) Gary Falk, MD – University of Pennsylvania Perelman School of Medicine
• Biologics and Immune Modulators: Charting a New Course Ikuo Hirano, MD – Northwestern University School of Medicine
• Therapeutics: Discussion Speaker Panel

BREAKOUTS

• Diet Therapy. SOFEED, Novel Monitoring Ready for Prime TimeJohn Leung MD, Nirmala Gonsalves, MD, Kara Kliewer, RD and Bethany Doerfler, RD
• Endpoints of Medical Therapy in Adults: Resolution of Inflammation David Katzka, MD, Margaret Collins, MD, Ikuo Hirano, MD, Jonathan Spergel, MD, PhD and Thomas Greuter, MD

SUMMARY OF BREAKOUT GROUPS

• Case Presentation-EGE: Adult Gary Falk, MD – University of Pennsylvania Perelman School of Medicine Patient Lisa L.
• Epidemiology: When and Where Did This Path Begin Elizabeth Jensen, PhD – Wake Forest School of Medicine
• Clinical Features and Natural History: A Long and Winding Road Chris Liacouras, MD – Children’s Hospital of Philadelphia
• Pathology: Diagnostic Thresholds for Eosinophil Density: New Roadmaps for an Old Disease Robert Genta, MD – Baylor College of Medicine
• Pathology: Histologic Features Beyond Eosinophils: Off the Beaten Path Margaret Collins, MD – Cincinnati Children’s Hospital Medical Center
• Pathogenesis: Building Bridges to Better Understanding Glenn Furuta, MD – Children’s Hospital Colorado
• Outcomes and Biomarkers: Inroads into Uncharted Territory? Paneez Khoury, MD, MHSc – National Institute of Health
• Therapeutics: Diet Therapies Nirmala Gonsalves, MD – Northwestern Memorial Hospital
• Therapeutics: Novel Directions Kathryn Peterson, MD – University of Utah
• Discussion Speaker Panel

Non-EGID Disorders: CROSSROADS: EOSINOPHILS IN NON EGID GI DISORDERS

• CON: Achalasia in Not an EGID John Pandolfino, MD – Northwestern University Consensus and Discussion Panel

INFLAMMATORY BOWEL DISEASE

• Introduction Glenn Furuta, MD – Children’s Hospital Colorado Role of Eosinophils in IBD
• Theresa Pizarro, PhD – Case Western Reserve University School of Medicine
• Remodeling in IBD. Lessons for EGIDs Florian Rieder, MD – Cleveland Clinic Foundation
• Management of IBD: Lessons for EGIDS Steven Hanauer, MD – Northwestern University Feinberg School of Medicine
• Summary, Discussion and Q&A Panel

FUNCTIONAL GASTROINTESTINAL DISORDERS

• Moderator Introduction John Pandolfino, MD – Northwestern University
• PRO: Functional GI disorders are EGIDs Nicholas Talley, MD, PhD – University of Sydney, Australia
• CON: Functional GI Disorders are Not EGIDs Brian Lacy, MD, PhD – Mayo Clinic